Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Mutation Profile and Prognosis in Acute Myeloid Leukemia With IDH1/2 Mutation

NCT07004816 is registered in ClinicalTrials.gov with Institute of Hematology & Blood Diseases Hospital, China as lead sponsor.

NCT NCT07004816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07004816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Mutation Profile and Prognosis in Acute Myeloid Leukemia With IDH1/2 Mutation
Lead sponsor
Institute of Hematology & Blood Diseases Hospital, China
Phase
Observational
Overall status
Terminated
Start date
December 21, 2017
Completion date
March 24, 2020
Enrollment
1,015 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aml